Delivery Order SPE2DE21D0029-SPE2D626F0632
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $3,573.30 fixed-price delivery order to Becton, Dickinson and Company (BD), Infectious Disease Systems division, on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and represents a task order under BD's existing federal contract vehicles. The work will be performed at BD's facility in Sparks Glencoe, Maryland. BD, a global medical technology...
- Becton, Dickinson and Company (BD) was awarded a delivery order valued at $225,791.91 on September 24, 2025, for other medical supplies and equipment. The contract is a firm fixed-price delivery order with no small business set-aside designation, with an ultimate completion date of October 29, 2026. Performance will take place at BD's facility in Franklin Lakes, New Jersey. The contract is funded by the Medical Supply Chain, a defense-focused federal agency, reflecting BD's ongoing role as a...
- Becton, Dickinson and Company's Infectious Diseases Systems division received a delivery order valued at $1,361.04 for the KIT AFFIRM VPIII CLINICAL from the Defense Health Agency's Medical Supply Chain division. Awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation. The work will be performed in Sparks Glencoe, Maryland. This delivery order represents a task order...
- Becton, Dickinson and Co (BD) was awarded a $437,837.49 firm fixed-price delivery order on September 24, 2025, by the Defense Health Agency's Medical Supply Chain division for medical supplies and equipment. The contract, which carries no small business set-aside designation, has an ultimate completion date of October 28, 2026, and will be performed at BD's facility in Franklin Lakes, New Jersey. As a leading global medical technology manufacturer, BD will deliver specialized medical devices and...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems (IDS) division, was awarded a delivery order valued at $104.3K by the Defense Health Agency for microbiology identification cards and antimicrobial susceptibility testing analyzer equipment along with associated reagents and consumables. The award, issued on October 1, 2025, carries a firm fixed price structure with an ultimate completion date of September 30, 2030, and will be performed in Sparks Glencoe, Maryland. This delivery...
- Becton, Dickinson and Company (BD) was awarded a firm fixed-price delivery order valued at $1,236.90 by the Defense Health Agency's Medical Supply Chain organization on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract, which carries no small business set-aside designation, is for delivery to Franklin Lakes, New Jersey. As a globally recognized medical technology manufacturer, BD specializes in providing sophisticated medical devices, diagnostic products, and...
- Becton, Dickinson and Company's Infectious Diseases Systems (IDS) division was awarded a delivery order valued at $998,100.60 by the Defense Health Agency for BD MAX and consumables—a handheld medical device that performs nucleic acid extraction. This firm fixed-price delivery order, effective through September 18, 2028, is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract. The award was made on a full and open competition basis...
- The Defense Logistics Agency Troop Support Medical awarded a $38,700 fixed-price with economic price adjustment delivery order contract to Becton, Dickinson and Company on June 30, 2020. Performance will take place in Sparks Glencoe, Maryland with an expected completion date of August 4, 2020. As the prime contractor, Becton, Dickinson and Company division Ids, doing business as BD Diagnostic Systems, will fulfill the contract under their corporate parent, also Becton, Dickinson and Company....
- Becton, Dickinson and Company's Infectious Diseases Systems (IDS) division received a $28,934.87 firm fixed price contract award from the Defense Health Agency on June 5, 2020, with performance completion scheduled for May 31, 2021. This Blanket Purchase Agreement (BPA) call covers Becton Dickinson reagents and consumables for Fort Belvoir Hospital, specifically aspartate aminotransferase test indicators and pipette tips for the Phoenix Automatic Microbiology System, along with associated...
- Becton, Dickinson and Company (BD), through its Infectious Disease Systems (IDS) division, was awarded a six-month bridge contract valued at $53,996.97 by the Department of Defense Medical Command for microbiology reagents, supplies, and testing equipment to support operations at Fort Belvoir, Virginia. The contract, awarded on October 1, 2025, under the designation W91YTZ20F0276, is structured as a firm fixed-price purchase order with no small business set-aside designation, reflecting BD's...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D626F0632Delivery Order
Becton, Dickinson and Company's Infectious Disease Systems (IDS) division was awarded a delivery order valued at $2,143.98 by the Department of Defense's Medical Supply Chain on October 7, 2025, with an ultimate completion date of October 29, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting the company's competitive standing as a large, established medical technology manufacturer. The work will be performed in Sparks Glencoe, Maryland, and represents a task order issued under one of BD's existing indefinite delivery vehicles or blanket purchase agreements with the Defense Health Agency or related DoD medical procurement mechanisms. As a leading global supplier of medical diagnostic technologies, BD's IDS division provides blood culture systems, microbiology analyzers, molecular testing kits, and related laboratory equipment to federal healthcare and research institutions. This delivery order aligns with BD's established portfolio of federal contracts supporting military and defense healthcare operations, continuing the company's role in delivering critical diagnostic and laboratory solutions across the DoD medical enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/7/25 |